Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

A Phase I Prospective Trial of Stereotactic Adaptive Radiation Therapy for Borderline Resectable/Locally Advanced Pancreatic Cancer: An Individualized Approach to Minimizing Gastrointestinal Toxicity (ARTIA-Pancreas)

Summary

The purpose of this trial is to evaluate the safety and efficacy of adaptive external beam radiation therapy delivered on Varian Ethos treatment system in patients with pancreatic cancer.

General Information

NCT#: NCT05764720
Study ID: VAR-2021-07
Trial Phase: Phase I

Trial Sponsor: Varian, a Siemens Healthineers Company, Washington University School of Medicine
Therapies Used in This Trial: Radiation Therapy, Varian Ethos treatment system

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search